Stanford Medicine: Lung disease and antibody levels contribute to long COVID, Stanford researchers find

Stanford Medicine: Lung disease and antibody levels contribute to long COVID, Stanford researchers find. “People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.”